Neuberger Berman Group
ORTX

Neuberger Berman Group’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Neuberger Berman Group’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,000
Closed -$301K – 1621
2020
Q1 		$301K Hold
4,000
– – ﹤0.01% 1339
2019
Q4 		$550K Buy
+4,000
New +$486K ﹤0.01% 1269

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Neuberger Berman Group's ORTX Position: Q2 2020 in Review

Neuberger Berman Group sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q2 2020, closing a stake of 4,000 shares — an estimated $301K sold.

Neuberger Berman Group first reported a position in ORTX in Q4 2019 and held it in 2 quarters. The position peaked at $550K in Q4 2019. 81 funds tracked by Wall St. Rank hold ORTX as of Q2 2020.

  • Neuberger Berman Group reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q2 2020 after selling out during the quarter.
  • Neuberger Berman Group sold 4,000 Orchard Therapeutics plc American Depositary Shares shares in Q2 2020, an estimated $301K.
  • Neuberger Berman Group first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2019 and held it in 2 quarters.
  • Neuberger Berman Group's Orchard Therapeutics plc American Depositary Shares position peaked at $550K in Q4 2019.
  • 81 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q2 2020.

Based on Neuberger Berman Group's 13F filing for Q2 2020, filed 13 Aug 2020.